2 March 2021 - In a national survey in January 2020 involving 1011 participants, the second-ranked domestic priority for members of ...
24 February 2021 - Verity-BCG bladder cancer treatment available for Canadian patients in the spring. ...
24 February 2021 - Adjunct Professor John Skerritt has tasked the nation’s medical regulator with ensuring COVID-19 tests are successfully ...
24 February 2021 - Treatment with autologous anti-CD19-transduced CD3+ cells (brexucabtagene autoleucel) is recommended for use within the Cancer Drugs Fund ...
24 February 2021 - NICE had intended to appraise omalizumab for the treatment of patients with chronic rhinosinusitis with nasal ...
24 February 2021 - Takeda Pharmaceutical Korea said that the Ministry of Health and Welfare would grant expanded reimbursement for ...
24 February 2021 - Takeda’s multiple myeloma treatment Ninlaro (ixazomib) and Novartis’ neuroendocrine tumour drug Lutathera (lutetium oxodotreotide) will get ...
24 February 2021 - ViiV Healthcare announced today the submission of a supplemental new drug application to the US FDA for ...
24 February 2021 - The Company’s second FDA Breakthrough Device designation granted in 2021. ...
24 February 2021 - EMA’s CHMP has started a ‘rolling review’ of data on the monoclonal antibody regdanvimab (also known ...
24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their medicines. ...
23 February 2021 - Antengene today announced that China's National Medical Products Administration has granted priority review to the new drug ...
23 February 2021 - Dupixent is the only biologic medicine approved to treat atopic dermatitis for this patient population. ...
23 February 2021 - If approved, the vaccine may help reduce the risk of tick-borne encephalitis for people traveling to endemic ...
23 February 2021 - Inovise Medical today announced the U.S. FDA has granted breakthrough device designation for its Audicor heart failure ...
24 February 2021 - Pharmacies, GPs and healthcare organisations will be banned from displaying advertisements identifying whether they are using ...